THC News & Analysis
4 articles
Market Mood
Medtronic (MDT) Reports 78% Revenue Growth in Q4 2026 Earnings
Medtronic plc (NYSE: MDT) achieved its highest annual revenue growth in a decade, reporting a global revenue increase of 78%, with 124% growth in the U.S. for its Cardiac Ablation Solutions. The company is focusing on innovations and acquisitions to support potential growth across its portfolio. In contrast, Tenet Healthcare Corporation (NYSE: THC) saw adjusted diluted EPS rise 52.2% year over year to $6.12, with net operating revenue climbing 6.8% to $5.63 billion. As both companies demonstrate strong performance, this information helps investors evaluate which stock might better suit their growth strategy.
Read More: Medtronic (MDT) Reports 78% Revenue Growth in Q4 2026 Earnings
Tenet Receives First Royalty Payment from Subsidiary in China
Tenet has received its first royalty payment from its subsidiary in China. The amount of this payment has not been disclosed in the article. This development indicates progress for Tenet's expansion and operations in the Chinese market. As Tenet grows its international footprint, the company may enhance its revenue streams, which could positively impact investor sentiment. This matters for ordinary investors as it signals potential growth opportunities for Tenet (THC).
Read More: Tenet Receives First Royalty Payment from Subsidiary in China
Tenet Healthcare (THC) Soars 70% Post Fair Value Alert
Tenet Healthcare (THC) experienced a significant increase of 70% following a Fair Value alert issued by InvestingPro. This surge indicates strong investor interest and could influence market views on the healthcare sector. Such a movement typically reflects a reassessment of the company's valuation, which could lead to increased trading volume and investor engagement. These developments may impact overall market sentiment towards healthcare stocks moving forward.
Read More: Tenet Healthcare (THC) Soars 70% Post Fair Value Alert
Tenet (THC) Reports $5.4 Billion Revenue in Q1 2026 Earnings Call
In Q1 2026, Tenet Healthcare (THC) reported net operating revenues of $5.4 billion and adjusted EBITDA of $1.16 billion, yielding an adjusted EBITDA margin of 21.6%. USPI contributed $484 million to adjusted EBITDA, a 6% increase from 2025, while same-facility revenues grew 5.3%. Despite challenges from winter storms and cyberattacks, the company rescheduled many procedures to mitigate impacts. They also invested $125 million in acquiring seven ASCs and began operations in three de novo centers, completing half of their full-year capital expenditure target in the first quarter.
Read More: Tenet (THC) Reports $5.4 Billion Revenue in Q1 2026 Earnings Call